Reducing age bias in decision analyses of anticoagulation for patients with nonvalvular atrial fibrillation - A microsimulation study.

Pubmed ID: 29995900

Pubmed Central ID: PMC6040745

Journal: PloS one

Publication Date: July 11, 2018

MeSH Terms: Humans, Male, Adult, Female, Aged, Aged, 80 and over, Age Factors, Middle Aged, Atrial Fibrillation, Severity of Illness Index, Stroke, Hospital Mortality, Mortality, Anticoagulants, Monte Carlo Method, Quality-Adjusted Life Years, Decision Support Techniques, Blood Coagulation, Models, Cardiovascular, Thrombolytic Therapy, Intracranial Hemorrhages

Authors: Pappas MA, Vijan S, Rothberg MB, Singer DE

Cite As: Pappas MA, Vijan S, Rothberg MB, Singer DE. Reducing age bias in decision analyses of anticoagulation for patients with nonvalvular atrial fibrillation - A microsimulation study. PLoS One 2018 Jul 11;13(7):e0199593. doi: 10.1371/journal.pone.0199593. eCollection 2018.

Studies:

Abstract

BACKGROUND: Anticoagulation decreases a patient's risk of ischemic stroke and increases the risk of hemorrhage. Decision analyses regarding anticoagulation therefore require that different outcomes be weighted in comparison to one another. Most decision analyses to date have weighted intracranial hemorrhage (ICH) as 1.5 times worse than ischemic stroke, but because death and disability have lifelong impact, the expected impact should vary by life expectancy. Therefore, a fixed weighting ratio leads to age-related bias decision analyses of anticoagulation. We aimed to quantify the relative impact of ICH and ischemic stroke and derive a ratio that allows decision analysis without microsimulation. METHODS: We created a microsimulation model to predict QALYs lost due to ICH and ischemic stroke. We then applied a meta-model to predict the ratio of QALYs lost from ICH relative to ischemic stroke. RESULTS: Previously-used weighting ratios (1.5) are close to our derived mean weighting ratio (1.60). However, the weighting ratio of QALYs lost from ICH relative to ischemic stroke is sensitive to age and discount rate. Patients at younger ages have higher mean weighting ratios, as do patients with higher discount rates. CONCLUSIONS: The ratio of QALYs lost to ICH relative to ischemic stroke varies with age and discount rate. We present a set of such ratios here for use in decision analyses that do not incorporate full microsimulation models. Use of weighting ratios that vary with age, rather than the current fixed ratios, has the potential to reduce age-based bias in decision-making regarding events with lifelong implications. In this case, use of dynamic ratios may change anticoagulation recommendations for patients with nonvalvular atrial fibrillation at relatively low stroke risk.